Clinical trials for high-dose oral semaglutide (such as the OASIS trial) have shown that a daily 25mg or 50mg pill can produce weight loss results reaching roughly 14% on average, putting it on par with weekly injections
Bupropion (Wellbutrin), another popular antidepressant, acts by inhibiting the reuptake of norepinephrine and dopamine
Phase 2: stepping up to 0.5mg (10 units) After four weeks at 0.25mg, the standard protocol doubles the dose to 0.5mg
Risk reduction In a trial of 17,000 adults, those taking the drug Wegovy were less likely to experience nonfatal heart attacks, nonfatal heart strokes or death due to cardiovascular causes than those taking a placebo
Research also suggests that by facilitating weight loss, GLP-1 medication can indirectly reduce the burden on your other systemshelping to improve symptoms of PCOS, knee osteoporosis, sleep Apnea and even substance use disorders